ANNEE 2020
Publié le 25/02/2021 à 09h19 (mis à jour le 13/05/2022 à 16h13)
PHARMACOVIGILANCE
Watson S, Durrieu G. Midostaurin, photosensitivity reaction. WHO Pharm. 2020 ;2:19.
ADDICTOVIGILANCE
PHARMACOÉPIDÉMIOLOGIE
Bagheri H. Characteristics of self-medication in French students. Therapies. 2020 ;75:417-418
Lacroix I, Bénévent J, Damase-Michel C. Chloroquine and hydroxychloroquine during pregnancy : What do we know ? Therapies. 2020 ;384-385.
Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. No increased risk of cataract in adult patients with primary immune thrombocytopenia treated with eltrombopag. A French nationwide nested case-control study. B J Haemat. 2020 ;189:e137-e140.
Lastennet D, Mariani LL, Rascol O, Turc JD, Alfaisal H, Lapeyre-Mestre M, Corvol JC, Tubach F. Evaluation of Prescription Practices of Domperidone in Parkinson’s Disease : A Cross Sectional Study Among French Neurologists. CNS Drugs. 2020 ;34:1267-1274.
Maquet J, Lafaurie M, Sommet A, Moulis G. Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19. Br J Haematol. 2020 ;190:e276-e279.
Montastruc F, Romano C, Montastruc JL, Silva S, Seguin T, Minville V, Georges B, Riu-Poulenc B, Fourcade O. Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France. Therapies. 2020 ;75:381-388.
Moulis G, Comont T, Germain J, Sommet A, Lapeyre-Mestre M, Beyne-Rauzy O, Adoue D ; CARMEN investigators group. Significance of antinuclear antibodies in primary immune thrombocytopenia : results of the CARMEN registry. Blood Adv. 2020 ;4:1974-1977.
Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2020 ;23:235-242.
Piel-Julian ML, Thiercelin-Legrand MF, Moulis G, Voisin S, Claeyssens S, Sailler L. Antithrombotic therapy management in patients with inherited bleeding disorders and coronary artery disease : A single-centre experience. Haemophilia. 2020 ;26:e34-e37.
Poncet M, Gardette V, Couret A, Renoux A, Lapeyre-Mestre M, Gallini A. Benzodiazepine exposure in subjects with incident Alzheimer’s disease and related syndromes in France : a longitudinal study 2011-2017. Int Clin Psychopharmacol. 2020 ;35:270-278.
Pugnet G, Mounié M, Lapeyre-Mestre M, Moulis G, Sailler L. Insufficient influenza vaccination coverage in giant cell arteritis. A French population-based study. Rev Med Interne. 2020 ;41:446-450.
Rascol O, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-Lloret S ; COPARK Study Group. Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort. J Neural Transm. 2020 ;127:1607-1617.
Rascol O, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-Lloret S ; COPARK Study Group. Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study. Drugs Aging. 2020 ;37:215-223.
Rascol O, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-Lloret S ; COPARK Study Group. Correction to : Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort. J Neural Transm. 2020. doi : 10.1007/s00702-020-02264-1.
Rousset S, Treiner E, Moulis G, Pugnet G, Astudillo L, Paricaud K, Puissant-Lubrano B, Arlet P, Blancher A, Sailler L. High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis. Rheumatology (Oxford). 2020 ;59:1006-1010.
Roustit R, Guilhaumou R, Molimard M, Drici MD, laporte S, Montastruc JL. On behalf of the French Society of Pharmacology and Therapeutics (SFPT). Chloroquine and hydroxychloroquine in the management of COVID-19 : Much kerfuffle but little evidence. Therapies. 2020 ;75:363-370.
Souty C, Launay T, Steichen O, Conte C, Turbelin C, Sarazin M, Vilcu AM, Rossignol L, Blanchon T, Lapeyre-Mestre M, Hanslik T. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions. Eur J Clin Pharmacol. 2020 ;76:1675-1682.
Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Herin F. Work adjustments and employment among breast cancer survivors : a French prospective study. Support Care Cancer. 2020 ;28:185-192.
Zacarin A, Pradalié P, Bourgade B, Bayle H, Mestery D, Bagheri H. Evolution of drug prescription pattern in elderly : Retrolective study in a general hospital center in France. Therapies. 2020 ;75:271-279.
PHARMACOLOGIE CLINIQUE
Barbe MT, Tonder L, Krack P, Debû B, Schüpbach M, Paschen S, Dembek TA, Kühn AA, Fraix V, Brefel-Courbon C, Wojtecki L, Maltête D, Damier P, Sixel-Döring F, Weiss D, Pinsker M, Witjas T, Thobois S, Schade-Brittinger C, Rau J, Houeto JL, Hartmann A, Timmermann L, Schnitzler A, Stoker V, Vidailhet M, Deuschl G ; EARLYSTIM study group. Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease With Early Motor Complications. Mov Disord. 2020 ;35:82-90.
Blin O, Lefebvre MN, Rascol O, Micallef J. Orphan drug clinical development. Therapies. 2020 ;75:141-147.
Boussac M, Arbus C, Dupouy J, Harroch E, Rousseau V, Ory-Magne F, Rascol O, Moreau C, Maltête D, Rouaud T, Meyer M, Houvenaghel JF, Marsé C, Tranchant C, Hainque E, Jarraya B, Ansquer S, Bonnet M, Belamri L, Tir M, Marques AR, Danaila T, Eusebio A, Devos D, Brefel-Courbon C ; PREDI-STIM study group*. Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson’s Disease Patients (PSYCHO-STIM). J Parkinsons Dis. 2020 ;10:1057-1066.
Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT, Rascol O ; AETIONOMY study group. Multicenter Alzheimer’s and Parkinson’s disease immune biomarker verification study. Alzheimers Dement. 2020 ;16:292-304.
Crepin S, Chiffoleau A, Gavard M, Olivier-Abbal P, Roussillon C, Ruault S, Muller C, Peyro-Saint-Paul L, Ouk T, Franceschi MP, Mouchel C, Duranton S, Petitpain N, Coubret-Dumas A. Compliance of French academic clinical trials with the Clinical Trial Facilitation and Coordination Group recommendations on contraception and pregnancy testing requirements. Clin Trials. 2020 ;17:314-322.
Del Campo N, Phillips O, Ory-Magne F, Brefel-Courbon C, Galitzky M, Thalamas C, Narr KL, Joshi S, Singh MK, Péran P, Pavy-LeTraon A, Rascol O. Broad white matter impairment in multiple system atrophy. Hum Brain Mapp. 2020 ;42:357-66.
Fabbri M, Kauppila LA, Ferreira JJ, Rascol O. Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease. J Parkinsons Dis. 2020 ;10:S75-S83.
Fabbri M, Perez-Lloret S, Rascol O. Therapeutic strategies for Parkinson’s disease : promising agents in early clinical development. Expert Opin Investig Drugs. 2020 ;29:1249-1267.
Gallais F, Ysebaert L, Despas F, De Barros S, Dupré L, Quillet-Mary A, Protin C, Thomas F, Obéric L, Allal B, Chatelut E, White-Koning M. Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies. Clin Pharmacokinet. 2020 ;59:1171-1183.
Grosset DG, Dhall R, Gurevich T, Kassubek J, Poewe WH, Rascol O, Rudzinska M, Cormier J, Sedkov A, Oh C. Inhaled levodopa in Parkinson’s disease patients with OFF periods : A randomized 12-month pulmonary safety study. Parkinsonism Relat Disord. 2020 ;71:4-10.
Kermorgant M, Nasr N, Czosnyka M, Arvanitis DN, Hélissen O, Senard JM, Pavy-Le Traon A. Impacts of Microgravity Analogs to Spaceflight on Cerebral Autoregulation. Front Physiol. 2021 Jul 3 ;11:778.
Kermorgant M, Ben Salem J, Iacovoni JS, Calise D, Dahan L, Guiard B, Lopez S, Lairez O, Lasbories A, Nasr N, Pavy Le-Traon A, Beaudry F, Senard JM, Arvanitis DN. Cardiac sensory afferents modulate susceptibility to anxio-depressive behaviour in a mouse model of chronic heart failure. Acta Physiol (Oxf). 2020 Dec 14:e13601.
Leal Rato M, Rascol O, Ferreira JJ. The "long and winding road" of the disease-modifying effects of levodopa has not ended yet. Mov Disord. 2020 ;35:397-399.
LeWitt PA, Aradi SD, Hauser RA, Rascol O. The challenge of developing adenosine A2A antagonists for Parkinson disease : Istradefylline, preladenant, and tozadenant. Parkinsonism Relat Disord. 2020 ;80:S54-S63.
Markaki I, Bergström S, Tsitsi P, Remnestål J, Månberg A, Hertz E, Paslawski W, Sorjonen K, Uhlén M, Mangone G, Carvalho S, Rascol O, Meissner WG, Magnin E, Wüllner U, Corvol JC, Nilsson P, Svenningsson P. Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson’s Disease. Mov Disord. 2020 ;35:2101-2106.
Meissner WG, Traon AP, Foubert-Samier A, Galabova G, Galitzky M, Kutzelnigg A, Laurens B, Lührs P, Medori R, Péran P, Sabatini U, Vergnet S, Volc D, Poewe W, Schneeberger A, Staffler G, Rascol O ; AFF009 Study Investigators. A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy. Mov Disord. 2020 ;35:1957-1965.
Meyrignac O, Bal L, Zadro C, Vavasseur A, Sewonu A, Gaudry M, Saint-Lebes B, De Masi M, Revel-Mouroz P, Sommet A, Darcourt J, Negre-Salvayre A, Jacquier A, Bartoli JM, Piquet P, Rousseau H, Moreno R. Combining Volumetric and Wall Shear Stress Analysis from CT to Assess Risk of Abdominal Aortic Aneurysm Progression.Radiology. 2020 ;295:722-729.
Pellecchia MT, Stankovic I, Fanciulli A, Krismer F, Meissner WG, Palma JA, Panicker J, Seppi K, Wenning GK, Antonini A, Bajaj S, Bang J, Barone P, Berardelli A, Berg D, Biaggioni I, Bloem B, Brooks DJ, Calandra‐Buonaura G, Colosimo C, Cortelli P, Ferreira J, Fox S, Frauscher B, Freeman R, Fung V, Gasser T, Gerhard A, D. Goldstein, Hallett M, Halliday G, Höglinger GU, Holton JL, Houlden H, Iodice V, Kaufmann H, Klockgether T, Kostic V, Lang A, Ling H, Low P, Litvan I, Miki Y, Nomura T, Orimo S, Ozawa T, Pantelyat A, Postuma R, Quinn N, Rascol O, Robertson D, Sabanovic M, Sakakibara R, Sampaio C, Schmahmann JD, Scholz S, Senard JM, Weintrau D, Siebert U, Poewe W. Can autonomic testing and imaging contribute to the early diagnosis of MSA ? A systematic review and recommendations by the MDS multiple system atrophy (MoDiMSA) study group. Mov Disord Clin Pract. 2020 ;7:750-762.
Phillipps C, Longato N, Béreau M, Carrière N, Lagha-Boukbiza O, Mengin AC, Monga B, Defebvre L, Ory-Magne F, Castrioto A, Lhommée E, Rascol O, Krack P, Tranchant C, Corvol JC, Anheim M. Is Motor Side Onset of Parkinson’s Disease a Risk Factor for Developing Impulsive-Compulsive Behavior ? A Cross-Sectional Study. Mov Disord. 2020 ;35:1080-1081.
Olivot JM, Albucher JF, Guenego A, Thalamas C, Mlynash M, Rousseau V, Drif A, Christensen S, Sommet A, Viguier A, Darcourt J, Calvière L, Menegon P, Raposo N, Januel AC, Bonneville F, Tourdias T, Mazighi M, Sibon I, Albers GW, Cognard C ; FRAME Investigators*. Mismatch Profile Influences Outcome After Mechanical Thrombectomy. Stroke. 2021 ;52:232-240.
Olivot JM, Albucher JF, Guenego A, Thalamas C, Mlynash M, Rousseau V, Drif A, Christensen S, Sommet A, Viguier A, Darcourt J, Calvière L, Menegon P, Raposo N, Januel AC, Bonneville F, Tourdias T, Mazighi M, Sibon I, Albers GW, Cognard C ; FRAME Investigators*. Mismatch Profile Influences Outcome After Mechanical Thrombectomy. Stroke. 2021 ;52:232-240.
Tolosa E, Vila M, Klein C, Rascol O. LRRK2 in Parkinson disease : challenges of clinical trials. Nat Rev Neurol. 2020 ;16:97-107.
INFORMATIONS SUR LE MEDICAMENT
Bagheri H. Analyse de livre. Automédication, le Guide Expert, J.-P. Giroud. Éditions De La Martinière, Paris (2017). 2020 ;75:125-126.
Montastruc JL. Analyse de livre. Le sport dans la douleur : de l’automédication au mental training, T. Bujon, F. Mougeot, in : Collections sports, cultures, sociétés, Presses universitaires de Grenoble, 38600, Fontaine, France (2017), 108 pp, ISBN : 9782706127038. Therapies. 2020 ;45:126.
Montastruc JL. Analyse de livre. Neuropsychopharmacologie, R. Bordet, L. Carton, J. Deguil, T. Dondaine, sous l’égide de la Société française de pharmacologie et de thérapeutique (SFPT) et du Collège national de pharmacologie médicale (CNPM), Elsevier Masson (2019), EISBN : 9782294754241, 277 pp., ISBN : 9782294752995. Therapies. 2020 ;75:126-127.
Partager cette page